UTILISATION D'INHIBITEURS DE POINTS DE CONTRÔLE IMMUNITAIRES DANS DES NÉOPLASMES DU SYSTÈME NERVEUX CENTRAL

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

申请号：

EP15871017.8

公开号：

EP3233123A4

申请日:

2015.12.16

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

This disclosure provides a method for treating glioma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating glioma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) anti-body and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/